Indaptus Therapeutics is trading 5.29% higher at $3.48 in after-hours trading, with no clear company-specific announcement identified to explain the move.
- The October 27 regular-session close was $3.31; shares ended the session down 1.05%.
- The previously reported private placement is earlier news, not a confirmed catalyst for the after-hours move.
- Broader indexes rose during the session, but available information does not establish a link to the stockβs after-hours gain.